Tom Cole

3.9k citations

17 papers · 476 indexed · h-index 10

Impact in

Microbiology top 5%
- Reproductive tract infections research
Virology top 10%
- HIV Research and Treatment

Papers in ⓘ

Virology 5
- HIV Research and Treatment 5
Epidemiology 4
- Hepatitis B Virus Studies 2

Co-authors: Robin J. Shattock (7 shared papers)David Barrett (1 shared paper)Mark D. Griffiths (1 shared paper)Hannah M. Cheeseman (3 shared papers)Leon R. McFarlane (3 shared papers)Suzanne Day (3 shared papers)Frank Follmann (1 shared paper)Sonya Abraham (1 shared paper)
Journals: Vaccine (3 papers)Journal of Clinical Oncology (2 papers)PLoS Pathogens (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)BMC Cancer (1 paper)
Partner nations: United Kingdom United States Italy

In The Last Decade

Tom Cole

16 papers receiving 471 citations

Peers

Countries citing papers authored by Tom Cole

Since Specialization

Citations

This map shows the geographic impact of Tom Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Cole more than expected).

Fields of papers citing papers by Tom Cole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Cole. The network helps show where Tom Cole may publish in the future.

Co-authors

The 25 scholars most cited alongside Tom Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tom Cole Line = papers co-authored together Tom Cole links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial The Lancet Infectious Diseases ·Sonya Abraham, Helene Bæk Juel, Peter Fibiger Bang, Hannah M. Cheeseman, Rebecca Bach Dohn, Tom Cole, Max P Kristiansen, Karen Smith Korsholm, David Lewis, Anja Weinreich Olsen, Leon R. McFarlane, Suzanne Day, Sara Knudsen, Kjersti Moen, Morten Rühwald, Ingrid Kromann, Peter Andersen, Robin J. Shattock, Frank Follmann	2019	135
2	Therapy-Induced Senescence Drives Bone Loss Cancer Research ·Zhangting Yao, Bhavna Murali, Qihao Ren, Xianmin Luo, Douglas V. Faget, Tom Cole, Biancamaria Ricci, Dinesh Thotala, Joseph B. Monahan, Jan M. van Deursen, Darren J. Baker, Roberta Faccio, Julie K. Schwarz, Sheila A. Stewart	2020	84
3	PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma BMC Cancer ·David J. Pinato, Alessio Cortellini, Ajithkumar Sukumaran, Tom Cole, Madhava Pai, Nagy Habib, Duncan Spalding, Mikael H. Sodergren, María Cristina Quijano Martínez, Tony Dhillon, Paul Tait, Robert Thomas, Caroline Ward, Hemant M. Kocher, Vincent Yip, Sarah Slater, Rohini Sharma	2021	58
4	Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally PLoS ONE ·D. J. Lewis, Carol Fraser, Abdel N. Mahmoud, Rebecca Wiggins, Maria Woodrow, Alethea Cope, Chun Cai, Rafaela Giemza, S. A. Jeffs, Maria Manoussaka, Tom Cole, Martin Cranage, Robin J. Shattock, Charles Lacey	2011	40
5	Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation Vaccine ·Martin Cranage, Carol Fraser, Alethea Cope, Paul F. McKay, Michael S. Seaman, Tom Cole, Abdel N. Mahmoud, Joanna Hall, Elaine Giles, Gérald Voss, Mark Page, Neil Almond, Robin J. Shattock	2010	33
6	Social Facilitation in Online and Offline Gambling: A Pilot Study International Journal of Mental Health and Addiction ·Tom Cole, David Barrett, Mark D. Griffiths	2010	32
7	Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen Vaccine ·Mauricio A. Arias, Andrew Loxley, Christy Eatmon, Griet Van Roey, David Fairhurst, Mark Mitchnick, Philip R. Dash, Tom Cole, Frank Wegmann, Quentin J. Sattentau, Robin J. Shattock	2010	25
8	Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms Vaccine ·Louise Donnelly, Rhonda M. Curran, John S. Tregoning, Paul F. McKay, Tom Cole, Ryan J. Morrow, Victoria Kett, Gavin P. Andrews, A. David Woolfson, Karl Malcolm, Robin J. Shattock	2011	21
9	Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines PLoS Pathogens ·Tamara Elliott, Hannah M. Cheeseman, Abbey Evans, Suzanne Day, Leon R. McFarlane, Jessica O’Hara, Mohini Kalyan, Fahimah Amini, Tom Cole, Alan Winston, Sarah Fidler, Katrina M. Pollock, James A. Harker, Robin J. Shattock	2022	15
10	[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer European Journal of Nuclear Medicine and Molecular Imaging ·Rohini Sharma, Pablo Oriol Valls, Marianna Inglese, Suraiya Dubash, Michelle Chen, Hani Gabra, Ana Montes, Amarnath Challapalli, Mubarik Arshad, George Tharakan, E.J. Chambers, Tom Cole, Jingky Lozano-Kühne, Tara Barwick, Eric O. Aboagye	2019	14
11	Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens Frontiers in Immunology ·Suzanne Day, Charandeep Kaur, Hannah M. Cheeseman, Emily de Groot, Leon R. McFarlane, Maniola Tanaka, Sofia Coelho, Tom Cole, Nana‐Marie Lemm, Adrian Lim, Rogier W. Sanders, Becca Asquith, Robin J. Shattock, Katrina M. Pollock	2022	7
12	An Empirical Study on Job Differentiation and Tenure The Journal of Applied Management and Entrepreneurship ·Steve Lovett, Tom Cole	2003	5
13	PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma. Journal of Clinical Oncology ·David J. Pinato, Alessio Cortellini, Madhava Pai, Duncan Spalding, Thomas Talbot, Robert Goldin, A. Gupta, Tom Cole, Caroline Ward, Vincent Yip, Tony Singh Dhillon, Sarah Slater, Mikael H. Sodergren, Paul Tait, Nagy Habib, Robert Thomas, Rohini Sharma	2021	3
14	Reservoir Characterization Based on Design and Operational Considerations Journal of Freshwater Ecology ·Robert H. Kennedy, Joan U. Clarke, William A. Boyd, Tom Cole	2002	2
15	The influence of barefoot and shod running on Triceps-surae muscle strain characteristics CLOK (University of Central Lancashire) ·Jonathan Sinclair, Tom Cole, Jim Richards	2016	1
16	[¹⁸F] Fluciclatide PET as a biomarker of clinical response to combination therapy of pazopanib and paclitaxel in patients with platinum-resistant or platinum-refractory advanced ovarian cancer: Results of a phase Ib study. Journal of Clinical Oncology ·Rohini Sharma, Pablo Oriol Valls, Marianna Inglese, Suraiya Dubash, Michelle Chen, Hani Gabra, Ana Montes, Amarnath Challapalli, George Tharakan, Edward S. Chambers, Tom Cole, Jingky Lozano-Kühne, Tara Barwick, Eric O. Aboagye	2019	1
17	Two-Dimensional Water Quality Modeling Using CE-QUAL-W2 on Selected Reservoirs SMARTech Repository (Georgia Institute of Technology) ·James L. Martin, Craig Hesterlee, Tom Cole	1999	0

About Tom Cole

Tom Cole is a scholar working on Virology, Epidemiology, Immunology, Molecular Biology and Oncology, having authored 17 papers that have together received 476 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), Immunotherapy and Immune Responses (3 papers), Reproductive tract infections research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cell Adhesion Molecules Research (2 papers), Hepatitis B Virus Studies (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Microbiology (98 citations), Virology (59 citations), Immunology (163 citations), Hepatology (49 citations) and Pharmaceutical Science (25 citations). Tom Cole has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robin J. Shattock, David Barrett, Mark D. Griffiths, Hannah M. Cheeseman, Leon R. McFarlane, Suzanne Day, Frank Follmann, Sonya Abraham, Ingrid Kromann and Max P Kristiansen. Their work appears in journals such as Vaccine, Journal of Clinical Oncology, PLoS Pathogens, European Journal of Nuclear Medicine and Molecular Imaging and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact